Abstract
Glycodelins (Gds) are glycoproteins with a gender specific glycosylation. Glycodelin A (GdA) is primarily produced in endometrial and decidual tissue and secreted to amniotic fluid. Glycodelins were also identified in several cancer types, including serous ovarian cancer. Gds act as a T-cell inhibitor and are involved in inactivation of human monocytes. With a Gd peptide antibody, derived from a 15 amino acid sequence of human Gd and in situ hybridization experiments, the expression of Gd in serous, mucinous, endometrioid and clear cell ovarian tumors was identified. In contrast to former investigations with antibodies against GdA, a positive immunohistochemical reaction for Gd was observed in all forms of epithelium ovarian cancer. These results were confirmed with in situ hybridization. In addition, Gd is expressed in granulose cell tumors, a non-epithelial form of ovarian cancer. Furthermore, Gd was purified from ascites fluid of ovarian cancer patients. Ascites Gd showed significant differences in its structure of sialyl Lewis-type oligosaccharides compared to GdA. Additionally, ascites Gd inhibits IL-2 stimulated proliferation of peripheral blood leucocytes and inhibits adhesion of SLeX-positive cells to E-selectin. Therefore, Gd could act as an inhibitor of lymphocyte activation and/or adhesion in ovarian cancer.
Similar content being viewed by others
References
Bischof A, Briese V, Richter DU, Bergemann C, Friese K, Jeschke U (2005) Measurement of glycodelin A in fluids of benign ovarian cysts, borderline tumours and malignant ovarian cancer. Anticancer Res 25:1639–1644
Bohn H, Kraus W, Winckler W (1982) New soluble placental tissue proteins: their isolation, characterization, localization and quantification. Placenta Suppl 4:67–81
Bolton AE, Pockley AG, Clough KJ, Mowles EA, Stoker RJ, Westwood OM, Chapman MG (1987) Identification of placental protein 14 as an immunosuppressive factor in human reproduction. Lancet 1:593–595
Clark GF, Dell A, Morris HR, Patankar MS, Easton RL (2001) The species recognition system: a new corollary for the human fetoembryonic defense system hypothesis. Cells Tissues Organs 168:113–121
Dell A, Morris HR, Easton RL, Panico M, Patankar M, Oehniger S, Koistinen R, Koistinen H, Seppala M, Clark GF (1995) Structural analysis of the oligosaccharides derived from glycodelin, a human glycoprotein with potent immunosuppressive and contraceptive activities. J Biol Chem 270:24116–24126
Fukuda M, Bothner B, Ramsamooj P, Dell A, Tiller PR, Varki A, Klock JC (1985) Structures of sialylated fucosyl polylactosaminoglycans isolated from chronic myelogenous leukemia cells. J Biol Chem 260:12957–12967
Grinnell BW, Hermann RB, Yan SB (1994) Human protein C inhibits selectin-mediated cell adhesion: role of unique fucosylated oligosaccharide. Glycobiology 4:221–225
Horowitz IR, Cho C, Song M, Flowers LC, Santanam N, Parthasarathy S, Ramachandran S (2001) Increased glycodelin levels in gynecological malignancies. Int J Gynecol Cancer 11:173–179
Jeschke U, Richter DU, Hammer A, Briese V, Friese K, Karsten U (2002) Expression of the Thomsen–Friedenreich antigen and of its putative carrier protein mucin 1 in the human placenta and in trophoblast cells in vitro. Histochem Cell Biol 117:219–226
Jeschke U, Richter DU, Walzel H, Bergemann C, Mylonas I, Sharma S, Keil C, Briese V, Friese K (2003a) Stimulation of hCG and inhibition of hPL in isolated human trophoblast cells in vitro by glycodelin A. Arch Gynecol Obstet 268:162–167
Jeschke U, Wang X, Briese V, Friese K, Stahn R (2003b) Glycodelin and amniotic fluid transferrin as inhibitors of E-selectin-mediated cell adhesion. Histochem Cell Biol 119:345–354
Jeschke U, Mylonas I, Richter DU, Streu A, Muller H, Briese V, Friese K (2004) Human amniotic fluid glycoproteins expressing sialyl Lewis carbohydrate antigens stimulate progesterone production in human trophoblasts in vitro. Gynecol Obstet Invest 58:207–211
Jeschke U, Bischof A, Speer R, Briese V, Richter DU, Bergemann C, Mylonas I, Shabani N, Friese K, Karsten U (2005a) Development of monoclonal and polyclonal antibodies and an ELISA for the determination of glycodelin in human serum, amniotic fluid and cystic fluid of benign and malignant ovarian tumors. Anticancer Res 25:1581–1589
Jeschke U, Karsten U, Reimer T, Richter DU, Bergemann C, Briese V, Mylonas I, Friese K (2005b) Stimulation of hCG protein and mRNA in first trimester villous cytotrophoblast cells in vitro by glycodelin A. J Perinat Med 33:212–218
Jeschke U, Kunert-Keil C, Mylonas I, Hammer A, Schiessl B, Lomba I, Kuhn C, Schulze S, Friese K (2005c) Expression of glycodelin A in decidual tissue of preeclamptic, HELLP and intrauterine growth-restricted pregnancies. Virchows Arch 446:360–368
Jeschke U, Mylonas I, Kunert-Keil C, Dazert E, Shabani N, Werling M, Kuhn C, Janni W, Gerber B, Friese K (2005d) Expression of glycodelin protein and mRNA in human ductal breast cancer carcinoma in situ, invasive ductal carcinomas, their lymph node and distant metastases, and ductal carcinomas with recurrence. Oncol Rep 13:413–419
Jeschke U, Richter DU, Briese V, Mylonas I, Friese K (2005e) Stimulation of HCG, estrogen and progesterone production in isolated trophoblast cells by glycodelin a or its N-glycans. Z Geburtshilfe Neonatol 209:59–64
Julkunen M (1986) Human decidua synthesizes placental protein 14 (PP14) in vitro. Acta Endocrinol (Copenh) 112:271–277
Julkunen M, Wahlstrom T, Seppala M, Koistinen R, Koskimies A, Stenman UH, Bohn H (1984) Detection and localization of placental protein 14-like protein in human seminal plasma and in the male genital tract. Arch Androl 12(Suppl):59–67
Julkunen M, Koistinen R, Sjoberg J, Rutanen EM, Wahlstrom T, Seppala M (1986) Secretory endometrium synthesizes placental protein 14. Endocrinology 118:1782–1786
Julkunen M, Seppala M, Janne OA (1988) Complete amino acid sequence of human placental protein 14: a progesterone-regulated uterine protein homologous to beta-lactoglobulins. Proc Natl Acad Sci USA 85:8845–8849
Kamarainen M, Riittinen L, Seppala M, Palotie A, Andersson LC (1994) Progesterone-associated endometrial protein: a constitutive marker of human erythroid precursors. Blood 84:467–473
Kamarainen M, Leivo I, Koistinen R, Julkunen M, Karvonen U, Rutanen EM, Seppala M (1996) Normal human ovary and ovarian tumors express glycodelin, a glycoprotein with immunosuppressive and contraceptive properties. Am J Pathol 148:1435–1443
Kamarainen M, Seppala M, Virtanen I, Andersson LC (1997) Expression of glycodelin in MCF-7 breast cancer cells induces differentiation into organized acinar epithelium. Lab Invest 77:565–573
Kamarainen M, Halttunen M, Koistinen R, von Boguslawsky K, von Smitten K, Andersson LC, Seppala M (1999) Expression of glycodelin in human breast and breast cancer. Int J Cancer 83:738–742
Keil C, Husen B, Giebel J, Rune G, Walther R (1999) Glycodelin mRNA is expressed in the genital tract of male and female rats (Rattus norvegicus). J Mol Endocrinol 23:57–66
Kirschning CJ, Schumann RR (2002) TLR2: cellular sensor for microbial and endogenous molecular patterns. Curr Top Microbiol Immunol 270:121–144
Koistinen H, Koistinen R, Dell A, Morris HR, Easton RL, Patankar MS, Oehninger S, Clark GF, Seppala M (1996) Glycodelin from seminal plasma is a differentially glycosylated form of contraceptive glycodelin-A. Mol Hum Reprod 2:759–765
Koistinen H, Easton RL, Chiu PC, Chalabi S, Halttunen M, Dell A, Morris HR, Yeung WS, Seppala M, Koistinen R (2003) Differences in glycosylation and sperm–egg binding inhibition of pregnancy-related glycodelin. Biol Reprod 69:1545–1551
Koopman LA, Kopcow HD, Rybalov B, Boyson JE, Orange JS, Schatz F, Masch R, Lockwood CJ, Schachter AD, Park PJ, Strominger JL (2003) Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med 198:1201–1212
Kunert-Keil C, Wiehmeier E, Jeschke U, Giebel J (2005) Immunolocalization of glycodelin in the genital tract of rats. J Mol Histol 36:111–117
Mandelin E, Lassus H, Seppala M, Leminen A, Gustafsson JA, Cheng G, Butzow R, Koistinen R (2003) Glycodelin in ovarian serous carcinoma: association with differentiation and survival. Cancer Res 63:6258–6264
Mazurkiewicz JE, Bank JF, Joshi SG (1981) Immunocytochemical localization of a progestagen-associated endometrial protein in the human decidua. J Clin Endocrinol Metab 52:1006–1008
Morris HR, Dell A, Easton RL, Panico M, Koistinen H, Koistinen R, Oehninger S, Patankar MS, Seppala M, Clark GF (1996) Gender-specific glycosylation of human glycodelin affects its contraceptive activity. J Biol Chem 271:32159–32167
Mukhopadhyay D, Sundereshan S, Rao C, Karande AA (2001) Placental protein 14 induces apoptosis in T cells but not in monocytes. J Biol Chem 276:28268–28273
Mylonas I, Speer R, Makovitzky J, Richter DU, Briese V, Jeschke U, Friese K (2000) Immunohistochemical analysis of steroid receptors and glycodelin A (PP14) in isolated glandular epithelial cells of normal human endometrium. Histochem Cell Biol 114:405–411
Mylonas I, Jeschke U, Makovitzky J, Winkler L, Richter DU, Friese K, Briese V (2003) Immunohistochemical expression of steroid receptors and glycodelin A in isolated proliferative human endometrial glandular cells after stimulation with tamoxifen and phytoestrogens (genistein and daidzein). Anticancer Res 23:1119–1125
Mylonas I, Jeschke U, Kunert-Keil C, Shabani N, Dian D, Bauerfeind I, Kuhn C, Kupka MS, Friese K (2006) Glycodelin A is expressed differentially in normal human endometrial tissue throughout the menstrual cycle as assessed by immunohistochemistry and in situ hybridization. Fertil Steril 86:1488–1497
Oehninger S, Coddington CC, Hodgen GD, Seppala M (1995) Factors affecting fertilization: endometrial placental protein 14 reduces the capacity of human spermatozoa to bind to the human zona pellucida. Fertil Steril 63:377–383
Ohyama C, Tsuboi S, Fukuda M (1999) Dual roles of sialyl Lewis X oligosaccharides in tumor metastasis and rejection by natural killer cells. EMBO J 18:1516–1525
Ohyama C, Kanto S, Kato K, Nakano O, Arai Y, Kato T, Chen S, Fukuda MN, Fukuda M (2002) Natural killer cells attack tumor cells expressing high levels of sialyl Lewis x oligosaccharides. Proc Natl Acad Sci USA 99:13789–13794
Okamoto N, Uchida A, Takakura K, Kariya Y, Kanzaki H, Riittinen L, Koistinen R, Seppala M, Mori T (1991) Suppression by human placental protein 14 of natural killer cell activity. Am J Reprod Immunol 26:137–142
Pockley AG, Bolton AE (1989) Placental protein 14 (PP14) inhibits the synthesis of interleukin-2 and the release of soluble interleukin-2 receptors from phytohaemagglutinin-stimulated lymphocytes. Clin Exp Immunol 77:252–256
Pockley AG, Bolton AE (1990) The effect of human placental protein 14 (PP14) on the production of interleukin-1 from mitogenically stimulated mononuclear cell cultures. Immunology 69:277–281
Pockley AG, Mowles EA, Stoker RJ, Westwood OM, Chapman MG, Bolton AE (1988) Suppression of in vitro lymphocyte reactivity to phytohemagglutinin by placental protein 14. J Reprod Immunol 13:31–39
Poddar AS, Kim JG, Gill KP, Bates BN, Santanam N, Rock JA, Murphy AA, Parthasarathy S (1998) Generation and characterization of a polyclonal antipeptide antibody to human glycodelin. Fertil Steril 69:543–548
Pugachev KK, Tatarinov IuS, Tsareva T, Shimbireva IB, Krivonosov SK (1990) The cellular localization of the fertility alpha 2-microglobulin in tumors of the reproductive system. Vopr Onkol 36:845–849
Rachmilewitz J, Riely GJ, Tykocinski ML (1999) Placental protein 14 functions as a direct T-cell inhibitor. Cell Immunol 191:26–33
Rachmilewitz J, Borovsky Z, Riely GJ, Miller R, Tykocinski ML (2003) Negative regulation of T cell activation by placental protein 14 is mediated by the tyrosine phosphatase receptor CD45. J Biol Chem 278:14059–14065
Renkonen J, Paavonen T, Renkonen R (1997) Endothelial and epithelial expression of sialyl Lewis(x) and sialyl Lewis(a) in lesions of breast carcinoma. Int J Cancer 74:296–300
Richter C, Baetje M, Bischof A, Makovitzky J, Richter DU, Gerber B, Briese V (2007) Expression of the glycodelin A gene and the detection of its protein in tissues and serum of ovarian carcinoma patients. Anticancer Res 27:2023–2025
Riittinen L (1992) Serous ovarian cyst fluids contain high levels of endometrial placental protein 14. Tumour Biol 13:175–179
Riittinen L, Narvanen O, Virtanen I, Seppala M (1991) Monoclonal antibodies against endometrial protein PP14 and their use for purification and radioimmunoassay of PP14. J Immunol Methods 136:85–90
Schindlbeck C, Jeschke U, Schulze S, Karsten U, Janni W, Rack B, Sommer H, Friese K (2005) Characterisation of disseminated tumor cells in the bone marrow of breast cancer patients by the Thomsen–Friedenreich tumor antigen. Histochem Cell Biol 123:631–637
Schindlbeck C, Jeschke U, Schulze S, Karsten U, Janni W, Rack B, Krajewski S, Sommer H, Friese K (2007) Prognostic impact of Thomsen–Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients. Breast Cancer Res Treat 101:17–25
Seppala M, Riittinen L, Julkunen M, Koistinen R, Wahlstrom T, Iino K, Alfthan H, Stenman UH, Huhtala ML (1988) Structural studies, localization in tissue and clinical aspects of human endometrial proteins. J Reprod Fertil Suppl 36:127–141
Seppala M, Taylor RN, Koistinen H, Koistinen R, Milgrom E (2002) Glycodelin: a major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiation. Endocr Rev 23:401–430
Shimizu Y, Kamoi S, Amada S, Akiyama F, Silverberg SG (1998) Toward the development of a universal grading system for ovarian epithelial carcinoma: testing of a proposed system in a series of 461 patients with uniform treatment and follow-up. Cancer 82:893–901
Shimodaira K, Nakayama J, Nakamura N, Hasebe O, Katsuyama T, Fukuda M (1997) Carcinoma-associated expression of core 2 beta-1, 6-N-acetylglucosaminyltransferase gene in human colorectal cancer: role of O-glycans in tumor progression. Cancer Res 57:5201–5206
Song M, Ramaswamy S, Ramachandran S, Flowers LC, Horowitz IR, Rock JA, Parthasarathy S (2001) Angiogenic role for glycodelin in tumorigenesis. Proc Natl Acad Sci USA 98:9265–9270
Stack MS, Ellerbroek SM, Fishman DA (1998) The role of proteolytic enzymes in the pathology of epithelial ovarian carcinoma. Int J Oncol 12:569–576
Stahn R, Schafer H, Kernchen F, Schreiber J (1998) Multivalent sialyl Lewis x ligands of definite structures as inhibitors of E-selectin mediated cell adhesion. Glycobiology 8:311–319
Tomczak S, Briese V, Kunkel S, Muller H (1996) Serum placental protein 14 (PP14) levels in patients with threatened abortion. Arch Gynecol Obstet 258:165–169
Uchida H, Maruyama T, Nagashima T, Asada H, Yoshimura Y (2005) Histone deacetylase inhibitors induce differentiation of human endometrial adenocarcinoma cells through up-regulation of glycodelin. Endocrinology 146:5365–5373
Uchida H, Maruyama T, Ohta K, Ono M, Arase T, Kagami M, Oda H, Kajitani T, Asada H, Yoshimura Y (2007a) Histone deacetylase inhibitor-induced glycodelin enhances the initial step of implantation. Hum Reprod 22:2615–2622
Uchida H, Maruyama T, Ono M, Ohta K, Kajitani T, Masuda H, Nagashima T, Arase T, Asada H, Yoshimura Y (2007b) Histone deacetylase inhibitors stimulate cell migration in human endometrial adenocarcinoma cells through up-regulation of glycodelin. Endocrinology 148:896–902
van Rooijen JJ, Jeschke U, Kamerling JP, Vliegenthart JF (1998) Expression of N-linked sialyl Le(x) determinants and O-glycans in the carbohydrate moiety of human amniotic fluid transferrin during pregnancy. Glycobiology 8:1053–1064
Vigne JL, Hornung D, Mueller MD, Taylor RN (2001) Purification and characterization of an immunomodulatory endometrial protein, glycodelin. J Biol Chem 276:17101–17105
Yaniv E, Borovsky Z, Mishan-Eisenberg G, Rachmilewitz J (2003) Placental protein 14 regulates selective B cell responses. Cell Immunol 222:156–163
Acknowledgments
We thank Dr. U. Karsten (NEMOD Biotherapeutics, Berlin, Germany) for providing the monoclonal antibodies used in this study, S. Kunze (1st Department of Obstetrics and Gynecology Ludwig Maximilians University of Munich, Munich, Germany), D.U. Richter (Department of Obstetrics and Gynecology, University of Rostock, Rostock, Germany) as well as J. Adolph (Institute of Pathology, Ernst Moritz Arndt University of Greifswald, Greifswald, Germany) for excellent technical assistance. Furthermore, we are grateful to Dr. R. Jarchow (Computing Center, University of Greifswald, Germany) for his support and to T. Shaw (former journalist of the “Daily Telegraph”) for the evaluation of English language.
Author information
Authors and Affiliations
Corresponding author
Additional information
U. Jeschke, I. Mylonas and C. Kunert-Keil contributed equally to this work.
Rights and permissions
About this article
Cite this article
Jeschke, U., Mylonas, I., Kunert-Keil, C. et al. Immunohistochemistry, glycosylation and immunosuppression of glycodelin in human ovarian cancer. Histochem Cell Biol 131, 283–295 (2009). https://doi.org/10.1007/s00418-008-0510-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00418-008-0510-z